142 results about "Known Coronary Artery Disease" patented technology

The invention discloses health-care vinegar which is prepared from the following preferable raw materials of barbary wolfberry fruits, honeysuckle flowers, dates, momordica grosvenori, ginger, hawthorns, licorice roots, mint and red-rooted salvia roots by the following steps of: pulverizing; adding water to soak; decocting; filtering decocted liquid; adding table vinegar to the liquid with a total weight part; fermenting; adding white sugar and a food additive; and sterilizing at high temperature, wherein the table vinegar is rice vinegar produced by the enterprise or Zhenjiang spiced vinegar (mature vinegar), and the food additive is potassium sorbate. The health-care vinegar is convenient to prepare and has the health-care effects of improving the immune competence, sterilizing, diminishing inflammation, digesting, reducing the blood pressure and the blood sugar, preventing coronary heart diseases and diabetes, and the like.

The invention relates to the field of medicine synthesis and discloses an exenatide analog. The exenatide analog disclosed by the invention is used for preparing a medicine composition for treating diseases. The invention discloses application of medicine composition in preparing medicines for treating at least one of the following diseases: type-II diabetes, impaired glucose tolerance, type-I diabetes, obesity, hypertension, metabolic syndrome, dyslipidemia, cognitive disorder, atherosclerosis, myocardial infarction, coronary heart diseases, cardiovascular diseases, stroke, inflammatory intestinal tract syndrome and / or dyspepsia or gastric ulcer, hepatic fibrosis diseases and pulmonary fibrosis diseases.

A peroxisome proliferator activated receptor regulator containing a carboxylic acid derivative of formula (I) (wherein all symbols are as defined in the specification), a non-toxic acid thereof or a hydrate thereof as active ingredient.Because of having an effect of regulating PPAR, a compound of formula (I) is useful as a hypoglycemic agent, a hypolipidemic agent, a preventive and / or a remedy for diseases associating metabolic disorders (diabetes, obesity, syndrome X, hypercholesterolemia, hyperlipoproteinemia, etc.), hyperlipemia, atherosclerosis, hypertension, circulatory diseases, overeating, coronary heart diseases, etc., an HDL cholesterol-elevating agent, an LDL cholesterol and / or VLDL cholesterol-lowering agent and a drug for relief from risk factors of diseases or syndrome X.

The invention discloses a method for refining water extract of a traditional Chinese medicine (TCM) composition. The TCM composition is composed of TCMs such as ginseng, radix ophiopogonis, fructus corni, salvia miltiorrhiza, fried spina date seeds, parasitic loranthus, red paeony root, ground beetle and rhizoma nardostachyos and can effectively treat premature ventricular contraction of coronary heart diseases. The method has the following beneficial effects: an inorganic ceramic membrane is adopted for filtration to refine the extract of the TCM composition; the active ingredients have high transfer rate; the extract can be industrially produced; the material liquid is simple to process; and the inorganic ceramic membrane is convenient to wash and can be regenerated.

The invention relates to a lipid-lowering intestine-moistening vinegar drink and a preparation method thereof, belonging to the field of brewage. The lipid-lowering intestine-moistening vinegar drink is prepared from ginkgo fruit, rhodiola root, Dendrobium nobile Lindl., haw juice, blueberry juice, sea-buckthorn fruit juice, ginseng, wolfberry, Chinese yam juice, Chinese-date, Cordyceps militaris, stevioside, xylooligosaccharide, vitamin, selenium-rich tablet and millet vinegar. On the basis of a secret prescription handed down from ancestors and summary of clinical experience of years, the vinegar drink is developed through repeated experiments; and the vinegar drink exerts unique curative effect on intractable hyperlipidemia as well as on hypertension, hyperlipidemia, constipation, encephalatrophy, cerebral thrombus, coronary heart diseases, cerebral arteriosclerosis and sequela of apoplexy, and has the advantages of fast action, a short treatment course, a high cure rate and low cost.

The invention discloses a health-care green tea capable of reducing blood pressure and blood fat. The health-care green tea is prepared from the following raw materials in parts by weight: 20-40 parts of green tea, 5-10 parts of radix puerariae, 5-8 parts of gynostemma pentaphyllum, 10-15 parts of bitter gourds, 4-7 parts of ginkgo leaves, 3-6 parts of honeysuckles, 7-10 parts of mulberry leaves, 2-5 parts of glabrous greenbrier rhizomes, 2-6 parts of cortex fraxini, 4-10 parts of purslane and 3-7 parts of natural indigo. The health-care green tea capable of reducing blood pressure and blood fat, provided by the invention, is good in mouth feel, can expand cerebral artery vessels and coronary artery vessels and reduce the stickiness of blood so as to achieve the purpose of adjusting the blood fat after being drunk for a long term, is significant in effects, is extremely suitable for treating high blood fat, and has a good effect of preventing and treating coronary heart diseases, high blood pressure and diabetes.

The invention discloses a Docynia delavayi polyphenol extract which has polyphenol content of 91.24 to 91.34% (w / w). The invention also provides a preparation method for the extract. With extraction conditions provided in the invention, polyphenol substances can be maximally extracted from Docynia delavayi, and an extraction rate is as high as 18.54%. High-purity polyphenol and phlorizin can be obtained by further purifying a crude extract with the purifying method provided by the invention. Pharmacological experiments show that the Docynia delavayi polyphenol extract can substantially reduce the levels of cholesterol TC, triglyceride TG, high-density lipoprotein HDL-C and low-density lipoprotein LDL-C in the serum of mice; thus, the Docynia delavayi polyphenol extract can effectively prevent and treat diseases related to abnormal lipids metabolism, such as obesity resulting from abnormal blood fat content, hyperlipidemia, atherosclerosis and coronary heart diseases.

The invention provides an antiarrhythmic traditional Chinese medicine composition, which is characterized in that it is made of the following raw materials in parts by weight: 40-200 parts of ginseng, 100-500 parts of astragalus, 400-650 parts of salvia miltiorrhiza, 50-400 parts of red peony , 50-450 parts of Ophiopogon japonicus and 1.5-4.5 parts of borneol. The present invention also provides a preparation method for the above-mentioned traditional Chinese medicine composition tablet, which includes the following steps: extracting active ingredients from five kinds of medicinal materials: ginseng, astragalus, salvia miltiorrhiza, red peony root, and radix japonicus to obtain a clear ointment; mixing the above-mentioned clear ointment, and preparing Granules: crush borneol, add to the above granules together with auxiliary material glidants, mix uniformly, compress into tablets, and coat with film to obtain Chinese medicine composition tablets. The traditional Chinese medicine composition provided by the invention is mainly suitable for treating arrhythmia of coronary heart disease, has definite curative effect, has no toxic and side effects, and has good safety; it is usually made into tablets and is convenient to take; it does not contain sugar and is suitable for patients.